Correction to: Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study

Lorenzo Iughetti¹, Franco Antoniazzi², Claudia Giavoli³, Simonetta Bellone⁴, Tommaso Aversa⁵, Laura Guazzarotti⁶, Maria Elisabeth Street⁷, Emanuele Miraglia Del Giudice⁸, Luca Persani^{9

10}, Gabriella Pozzobon¹¹, Letizia Ragusa¹², Stefano Stagi^{13

14}, Gianluca Tornese^{15

16}, Clara Zecchino¹⁷, Chiara Mameli¹⁸, Emiliano Zecchi¹⁹, Paolo Fedeli¹⁹, Markus Zabransky²⁰, Laura Lucaccioni²¹, Stefano Zucchini²²

Affiliations

¹ Pediatric Unit, Department of Medical and Surgical Sciences for Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy. lorenzo.iughetti@unimore.it.
² Pediatric Clinic C, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
³ Endocrinology Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
⁵ Pediatric Unit, Department of Human Pathology of Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
⁶ Pediatric Endocrinology Unit, University of Padova, Padova, Italy.
⁷ Department of Medicine and Surgery, Unit of Paediatrics, University Hospital of Parma, Parma, Italy.
⁸ Department of General and Specialized Surgery for Women and Children, Università degli Studi Luigi Vanvitelli, Napoli, Italy.
⁹ Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.
¹⁰ Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
¹¹ Paediatric Department San Raffaele Hospital, Vita-Salute University San Raffaele, Milan, Italy.
¹² Department of Intellectual Disabilities, Pediatric and Medical Genetics Unit, Oasi Research Institute-I.R.C.C.S., Troina, Enna, Italy.
¹³ Health Sciences Department, University of Florence, Florence, Italy.
¹⁴ Auxoendocrinologia, Ospedale Pediatrico Meyer IRCCS, Florence, Italy.
¹⁵ Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
¹⁶ Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
¹⁷ Department of Biomedical Sciences and Human Oncology, AO Policlinico of Bari, Giovanni XXIII Hospital, Bari, Italy.
¹⁸ Department of Pediatrics, V. Buzzi Children Hospital, University of Milan, Milan, Italy.
¹⁹ Sandoz S.p.A, Milan, Italy.
²⁰ Sandoz Biopharmaceutical c/o HEXAL AG, Holzkirchen, Germany.
²¹ Pediatric Unit, Department of Medical and Surgical Sciences for Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
²² Pediatric Unit, IRCCS AOU of Bologna, Bologna, Italy.

PMID: 39883391
DOI: 10.1007/s12020-025-04162-6

Published Erratum

Correction to: Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study

Lorenzo Iughetti et al. Endocrine. 2025 May.

. 2025 May;88(2):668-669.

doi: 10.1007/s12020-025-04162-6.

Authors

Affiliations

¹ Pediatric Unit, Department of Medical and Surgical Sciences for Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy. lorenzo.iughetti@unimore.it.
² Pediatric Clinic C, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
³ Endocrinology Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
⁵ Pediatric Unit, Department of Human Pathology of Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
⁶ Pediatric Endocrinology Unit, University of Padova, Padova, Italy.
⁷ Department of Medicine and Surgery, Unit of Paediatrics, University Hospital of Parma, Parma, Italy.
⁸ Department of General and Specialized Surgery for Women and Children, Università degli Studi Luigi Vanvitelli, Napoli, Italy.
⁹ Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.
¹⁰ Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
¹¹ Paediatric Department San Raffaele Hospital, Vita-Salute University San Raffaele, Milan, Italy.
¹² Department of Intellectual Disabilities, Pediatric and Medical Genetics Unit, Oasi Research Institute-I.R.C.C.S., Troina, Enna, Italy.
¹³ Health Sciences Department, University of Florence, Florence, Italy.
¹⁴ Auxoendocrinologia, Ospedale Pediatrico Meyer IRCCS, Florence, Italy.
¹⁵ Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
¹⁶ Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
¹⁷ Department of Biomedical Sciences and Human Oncology, AO Policlinico of Bari, Giovanni XXIII Hospital, Bari, Italy.
¹⁸ Department of Pediatrics, V. Buzzi Children Hospital, University of Milan, Milan, Italy.
¹⁹ Sandoz S.p.A, Milan, Italy.
²⁰ Sandoz Biopharmaceutical c/o HEXAL AG, Holzkirchen, Germany.
²¹ Pediatric Unit, Department of Medical and Surgical Sciences for Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
²² Pediatric Unit, IRCCS AOU of Bologna, Bologna, Italy.

PMID: 39883391
DOI: 10.1007/s12020-025-04162-6

No abstract available

PubMed Disclaimer

Erratum for

Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope^®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study.
Iughetti L, Antoniazzi F, Giavoli C, Bellone S, Aversa T, Guazzarotti L, Street ME, Miraglia Del Giudice E, Persani L, Pozzobon G, Ragusa L, Stagi S, Tornese G, Zecchino C, Mameli C, Zecchi E, Fedeli P, Zabransky M, Lucaccioni L, Zucchini S. Iughetti L, et al. Endocrine. 2025 Mar;87(3):933-942. doi: 10.1007/s12020-024-04090-x. Epub 2024 Nov 29. Endocrine. 2025. PMID: 39612101

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study

Affiliations

Correction to: Long-term safety and effectiveness of a somatropin biosimilar (Omnitrope®) in children requiring growth hormone therapy: analysis of final data of Italian patients enrolled in the PATRO children study

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources